![](/images/graphics-bg.png)
Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
Joint Authors
Vorobyeva, Anzhelika
Bragina, Olga
Altai, Mohamed
Mitran, Bogdan
Orlova, Anna
Shulga, Alexey
Proshkina, Galina
Chernov, Vladimir
Tolmachev, Vladimir
Deyev, Sergey
Source
Contrast Media & Molecular Imaging
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-06-06
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
High expression of human epidermal growth factor receptor 2 (HER2) in breast and gastroesophageal carcinomas is a predictive biomarker for treatment using HER2-targeted therapeutics (antibodies trastuzumab and pertuzumab, antibody-drug conjugate trastuzumab DM1, and tyrosine kinase inhibitor lapatinib).
Radionuclide molecular imaging of HER2 expression might permit stratification of patients for HER2-targeting therapies.
In this study, we evaluated a new HER2-imaging probe based on the designed ankyrin repeat protein (DARPin) 9_29.
DARPin 9_29 was labeled with iodine-125 by direct radioiodination and with [99mTc]Tc(CO)3 using the C-terminal hexahistidine tag.
DARPin 9_29 preserved high specificity and affinity of binding to HER2-expressing cells after labeling.
Uptake of [125I]I-DARPin 9_29 and [99mTc]Tc(CO)3-DARPin 9_29 in HER2-positive SKOV-3 xenografts in mice at 6 h after injection was 3.4 ± 0.7 %ID/g and 2.9 ± 0.7 %ID/g, respectively.
This was significantly (p<0.00005) higher than the uptake of the same probes in HER2-negative Ramos lymphoma xenografts, 0.22 ± 0.09 %ID/g and 0.30 ± 0.05 %ID/g, respectively.
Retention of [125I]I-DARPin 9_29 in the lung, liver, spleen, and kidneys was appreciably lower compared with [99mTc]Tc(CO)3-DARPin 9_29, which resulted in significantly (p<0.05) higher tumor-to-organ ratios.
The biodistribution data were confirmed by SPECT/CT imaging.
In conclusion, radioiodine is a preferable label for DARPin 9_29.
American Psychological Association (APA)
Vorobyeva, Anzhelika& Bragina, Olga& Altai, Mohamed& Mitran, Bogdan& Orlova, Anna& Shulga, Alexey…[et al.]. 2018. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors. Contrast Media & Molecular Imaging،Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1131514
Modern Language Association (MLA)
Vorobyeva, Anzhelika…[et al.]. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors. Contrast Media & Molecular Imaging No. 2018 (2018), pp.1-11.
https://search.emarefa.net/detail/BIM-1131514
American Medical Association (AMA)
Vorobyeva, Anzhelika& Bragina, Olga& Altai, Mohamed& Mitran, Bogdan& Orlova, Anna& Shulga, Alexey…[et al.]. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors. Contrast Media & Molecular Imaging. 2018. Vol. 2018, no. 2018, pp.1-11.
https://search.emarefa.net/detail/BIM-1131514
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1131514